Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Sheldon Sloan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $399.66M of SYRE open-market activity in the last 12 months
- Cameron Turtle - $8.23M of SYRE open-market activity in the last 12 months
- Michael Thomas Henderson - $7.95M of SYRE open-market activity in the last 12 months
- Scott L. Burrows - $4.88M of SYRE open-market activity in the last 12 months
- Jeffrey W. Albers - $2.40M of SYRE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Sheldon Sloan?
Sheldon Sloan is a corporate insider, tracked as Chief Medical Officer of Spyre Therapeutics, Inc. (SYRE). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sheldon Sloan submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Sheldon Sloan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 11 open-market sales ($7.35M) across all tracked filings.
Where can I see all of Sheldon Sloan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Sheldon Sloan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
